Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706901 · ClinicalTrials.gov registry record · NA
Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT00706901: Completed NA study, sponsored by VA Office of Research and Development.
NCT00706901 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00706901, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
Two approaches for providing evidence-based substance abuse treatment (EBT), group motivational interviewing (GMI) and the In-Home-Messaging-Device (IHMD), are interventions that have the characteristic ability for increasing accessibility to evidence-based treatment among patients with substance use problems and are proposed for investigation. GMI is based on motivational interviewing, an intervention that has shown consistent significant effects in promoting treatment retention and reduced substance use among individuals with substance use disorders, and is delivered in a group format. IHMD is a user-friendly computerized Tele-mental Health communication tool that allows interaction through the telephone line between a Veteran and the health care provider in an individual's home or residential placement. The current proposal aims to determine whether GMI and IHMD lead to a significantly greater increase in treatment engagement and reduction in alcohol use compared to a treatment control condition (TCC) among Veterans with a substance use problem and a co-existing psychiatric disorder.
Interventions
- BEHAVIORAL Arm 1 GMI
- BEHAVIORAL Arm 2 IHMD
- BEHAVIORAL Arm 3 TCC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2010-05-03 |
| Est. Completion | 2013-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00706901
The ClinicalTrials.gov registry entry for NCT00706901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Arm 1 GMI is the first listed.
NCT00706901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00706901 about?
NCT00706901 is a clinical study titled "Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans". Two approaches for providing evidence-based substance abuse treatment (EBT), group motivational interviewing (GMI) and the In-Home-Messaging-Device (IHMD), are interventions that have the characteristic ability for increasing accessibility to evidence-based treatment among patients with substance us...
What is the current status of trial NCT00706901?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2010-05-03. Estimated completion is 2013-09-30.
What interventions are being tested in trial NCT00706901?
The interventions under investigation include: Arm 1 GMI (BEHAVIORAL), Arm 2 IHMD (BEHAVIORAL), Arm 3 TCC (BEHAVIORAL).
Who is sponsoring clinical trial NCT00706901?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.